Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Zinc can help with some skin problems, but its effectiveness varies depending on the condition.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia is a key indicator of thallium poisoning.

Immune cells affect hair growth and could lead to new hair loss treatments.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Skin fat plays a key role in immune defense and healing beyond just storing energy.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Non-drug therapies show promise for hair regrowth but need more research.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

To diagnose hair loss, use a systematic approach including history, exams, and tests.